Nephros Inc (NEPH)

Currency in USD
2.910
-0.040(-1.36%)
Closed·
2.9100.000(0.00%)
·
NEPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.8102.990
52 wk Range
1.5106.420
Key Statistics
Prev. Close
2.95
Open
2.94
Day's Range
2.81-2.99
52 wk Range
1.51-6.42
Volume
83.3K
Average Volume (3m)
50.14K
1-Year Change
87.7419%
Book Value / Share
0.96
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NEPH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.000
Upside
+140.55%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Nephros Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Nephros Inc Earnings Call Summary for Q4/2025

  • Nephros posted Q4 EPS of $0.01 vs. forecast -$0.01; revenue reached $4.7M, beating estimates by 14.36% with 22% YoY growth.
  • Full-year 2025 net income surged to $1.2M from $0.1M in 2024, marking second consecutive profitable year despite stock declining 3.31%.
  • Gross margin compressed to 58% from 64% YoY due to tariff pressures, though company maintains 63% margin over trailing twelve months.
  • Management prioritizes expansion into non-patient care markets and product innovation, anticipating 31% revenue growth for fiscal 2025.
  • CEO cited strategic market diversification yielding results; CFO acknowledged tariff headwinds while emphasizing operational efficiency gains.
Last Updated: 2026-03-12, 06:30 p/m
Read Full Transcript

Compare NEPH to Peers and Sector

Metrics to compare
NEPH
Peers
Sector
Relationship
P/E Ratio
25.9x18.5x12.3x
PEG Ratio
0.020.310.03
Price/Book
3.0x1.3x1.4x
Price / LTM Sales
1.6x0.8x1.2x
Upside (Analyst Target)
140.5%60.5%26.4%
Fair Value Upside
Unlock27.3%8.2%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 7.000
(+140.55% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Benchmark
Buy6.00+106.19%6.00MaintainMar 18, 2026
Benchmark
Buy5.00+71.82%5.00MaintainAug 12, 2025
Maxim Group
Buy6.00+106.19%4.50MaintainAug 08, 2025

Earnings

Latest Release
Mar 12, 2026
EPS / Forecast
0.01 / -0.01
Revenue / Forecast
4.7M / 4.11M
EPS Revisions
Last 90 days

NEPH Income Statement

People Also Watch

19.6200
PRE
-7.23%
17.95
NN
-3.18%
4.850
RERE
-5.64%
18.12
ACFN
-5.08%

FAQ

What Is the Nephros (NEPH) Stock Price Today?

The Nephros stock price today is 2.910 USD.

What Stock Exchange Does Nephros Trade On?

Nephros is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Nephros?

The stock symbol for Nephros is "NEPH."

What Is the Nephros Market Cap?

As of today, Nephros market cap is 30.970M USD.

What Is Nephros's Earnings Per Share (TTM)?

The Nephros EPS (TTM) is 0.110.

When Is the Next Nephros Earnings Date?

Nephros will release its next earnings report on May 07, 2026.

From a Technical Analysis Perspective, Is NEPH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Nephros Stock Split?

Nephros has split 2 times.

How Many Employees Does Nephros Have?

Nephros has 36 employees.

What is the current trading status of Nephros (NEPH)?

As of Mar 22, 2026, Nephros (NEPH) is trading at a price of 2.910 USD, with a previous close of 2.950 USD. The stock has fluctuated within a day range of 2.810 USD to 2.990 USD, while its 52-week range spans from 1.510 USD to 6.420 USD.

What Is Nephros (NEPH) Price Target According to Analysts?

The average 12-month price target for Nephros is 7.000 USD, with a high estimate of 8 USD and a low estimate of 6 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +140.55% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.